Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idecâ€™s total revenues grew 29 percent over 2007 to $4.1 billion.
|Museum of Science||9/12||Grant||$1M||1|
|Virdante Pharmaceuticals||11/09||Series A||$30M||6|
|Raven Biotechnologies||10/05||Series D||$48.3M||12|